Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LDOC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZMIZ1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RDH8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YWHAB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ADGRL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507577 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTRB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C20orf78 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PCDHA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP1B3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUP210L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf50 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on